Temporal scRNA-seq and T-cell receptor (TCR) sequencing analyses have shown that Texp (precursor-exhausted T cells) tend to accumulate in lung cancer and are significantly reduced after PD-L1 therapy (35). The gene discussed is CD274; the disease is lung cancer.